Uromigos-EAU
Episode 309: EAU 24 CheckMate-274 - OS for Adjuvant Nivolumab
The UromigosThe Uromigos | April 8, 2024
Dr. Galsky describes the OS signal data from CheckMate-274 on adjuvant nivolumab for muscle-invasive bladder cancer.
Listen Now
Episode 308: EAU 24 IMvigor011 - Outcome of ctDNA-Negative Patients Post-Cystectomy
The UromigosThe Uromigos | April 8, 2024
Dr. Matt Galsky, Brian, and Tom discuss the IMvigor011 trial data that was presented at EAU 2024.
Listen Now
The Uromigos Episode 117: PD1/VEGF Adverse Event Management in Renal Cancer
GU Oncology Now EditorsThe Uromigos | September 21, 2022
Betsy Plimack discusses the tricks of the trade for adverse event management.
Listen Now
The Uromigos Episode 119: EAU—Surgery in Urothelial Cancer
The UromigosThe Uromigos | February 17, 2023
Dr. Ashish Kamat walks through ongoing issues around surgery in urothelial cancer at EAU 2021.
Listen Now
The Uromigos Episode 118: Prostate Cancer Highlights at EAU
The UromigosThe Uromigos | July 20, 2021
Peter Albers talks about exciting updates in prostate cancer research and picks his three highlights from EAU21.
Listen Now
The Uromigos Episode 116: Renal Cancer Surgery Controversies at EAU
The UromigosThe Uromigos | July 14, 2021
Dr. Grant Stewart discusses renal cancer data presented at the 2021 EAU Conference.
Listen Now
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2024 Mashup Media, LLC. All rights reserved.

    Terms of Use | Privacy Policy